Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Seize the engine: Emerging cell cycle targets in breast cancer. | Clin Transl Med | 2024 | 38264947 | PubTator, text mining | PubMed |
| Discovery of novel and potent CDK8 inhibitors for the treatment of acute myeloid leukaemia. | J Enzyme Inhib Med Chem | 2024 | 38258519 | PubTator, text mining | PubMed |
| Human Nutrition Research in the Data Era: Results of 11 Reports on the Effects of a Multiple-Micronutrient-Intervention Study. | Nutrients | 2024 | 38257081 | PubTator, text mining | PubMed |
| What to Make of Zero: Resolving the Statistical Noise from Conformational Reorganization in Alchemical Binding Free Energy Estimates with Metadynamics Sampling. | J Chem Theory Comput | 2024 | 38252868 | PubTator, text mining | PubMed |
| Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing. | Chem Biol Drug Des | 2024 | 38230791 | PubTator, text mining | PubMed |
| Enhancer-activated RET confers protection against oxidative stress to KMT2A-rearranged acute myeloid leukemia. | Cancer Sci | 2024 | 38226414 | PubTator, text mining | PubMed |
| CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value. | J Immunother Cancer | 2024 | 38212126 | PubTator, text mining | PubMed |
| Binding Free Energy Calculation Based on the Fragment Molecular Orbital Method and Its Application in Designing Novel SHP-2 Allosteric Inhibitors. | Int J Mol Sci | 2024 | 38203841 | PubTator, text mining | PubMed |
| Expanding the phenotypic spectrum for CDK8-related disease: A case report. | Am J Med Genet A | 2024 | 38193604 | PubTator, text mining | PubMed |
| Suppression of DNMT1 combined with ATM or ATR inhibitor as a therapeutic combination of acute myeloid leukemia. | Anticancer Drugs | 2024 | 38164802 | PubTator, text mining | PubMed |
| Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival. | Brain Commun | 2024 | 38162899 | PubTator, text mining | PubMed |
Secreted insulin-like growth factor binding protein 5 functions as a tumor suppressor and chemosensitizer through inhibiting insulin-like growth factor 1 receptor/protein kinase B pathway in acute myeloid leukemia. | Neoplasia | 2024 | 38159363 | PubTator, text mining | PubMed |
| OpenMM 8: Molecular Dynamics Simulation with Machine Learning Potentials. | J Phys Chem B | 2024 | 38154096 | PubTator, text mining | PubMed |
| Comprehensive analysis of the proximity-dependent nuclear interactome for the oncoprotein NOTCH1 in live cells. | J Biol Chem | 2024 | 38043798 | PubTator, text mining | PubMed |
| The reversible inhibitor SR-4835 binds Cdk12/cyclin K in a noncanonical G-loop conformation. | J Biol Chem | 2024 | 38016516 | PubTator, text mining | PubMed |
| PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma. | Endocr Connect | 2024 | 37992487 | PubTator, text mining | PubMed |
| Study of the PI3K/Akt/mTOR signaling pathway in vitro and molecular docking analysis of periplocin inhibits cell cycle progression and induces apoptosis in MDA-MB-231. | Environ Toxicol | 2024 | 37792628 | PubTator, text mining | PubMed |
| WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. | Genes Dis | 2024 | 37692481 | PubTator, text mining | PubMed |
| The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review. | Reprod Sci | 2024 | 37516697 | PubTator, text mining | PubMed |
| Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches. | Mol Divers | 2024 | 36670282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=8